Smile-Link Healthcare Global Berhad (KLSE:SMILE)
Malaysia · Delayed Price · Currency is MYR 0.1000
+0.0050 (5.26%)
At close: Apr 29, 2026
KLSE:SMILE Ratios and Metrics
Market cap in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25 | 32 | 40 | 43 | 48 | 49 | |
Market Cap Growth | -23.08% | -21.88% | -5.21% | -10.52% | -2.56% | -11.36% |
Enterprise Value | 33 | 39 | 51 | 55 | 56 | 53 |
Last Close Price | 0.10 | 0.13 | 0.16 | 0.17 | 0.19 | 0.19 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 467.86 | 47.52 | - |
PS Ratio | 1.05 | 1.15 | 1.20 | 1.21 | 1.38 | 1.58 |
PB Ratio | 0.86 | 1.08 | 1.37 | 1.28 | 1.44 | 1.51 |
P/TBV Ratio | 1.29 | 1.64 | 2.07 | 1.80 | 2.03 | 2.15 |
P/FCF Ratio | 7.64 | 7.76 | 11.77 | 1330.49 | - | 9.80 |
P/OCF Ratio | 7.63 | 7.22 | 9.55 | 52.63 | 29.58 | 7.01 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.35 | 1.43 | 1.52 | 1.56 | 1.63 | 1.71 |
EV/EBITDA Ratio | 12.40 | 93.47 | 1427.18 | 16.34 | 10.05 | 48.50 |
EV/EBIT Ratio | - | - | - | 44.41 | 21.94 | - |
EV/FCF Ratio | 9.87 | 9.63 | 14.89 | 1722.15 | - | 10.62 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.36 | 0.39 | 0.36 | 0.51 | 0.33 |
Debt / EBITDA Ratio | 3.51 | 3.15 | 2.79 | 2.61 | 2.35 | 2.09 |
Debt / FCF Ratio | 2.79 | 2.58 | 3.34 | 377.00 | - | 2.16 |
Net Debt / Equity Ratio | 0.25 | 0.26 | 0.30 | 0.32 | 0.35 | 0.24 |
Net Debt / EBITDA Ratio | -12.83 | 18.07 | 242.88 | 3.18 | 2.05 | 7.06 |
Net Debt / FCF Ratio | 2.21 | 1.86 | 2.53 | 335.44 | -40.17 | 1.55 |
Asset Turnover | - | 0.61 | - | 0.69 | 0.69 | 0.67 |
Inventory Turnover | - | 3.62 | - | 3.33 | 3.12 | 2.54 |
Quick Ratio | 1.16 | 1.14 | 0.96 | 1.10 | 0.85 | 0.99 |
Current Ratio | 1.54 | 1.47 | 1.35 | 1.49 | 1.35 | 1.73 |
Return on Equity (ROE) | - | -0.54% | - | 0.41% | 3.17% | -5.47% |
Return on Assets (ROA) | - | -1.99% | - | 1.52% | 3.19% | -2.18% |
Return on Invested Capital (ROIC) | -5.33% | 3.48% | -5.46% | 1.91% | 3.95% | -4.13% |
Return on Capital Employed (ROCE) | -6.20% | -4.30% | -7.10% | 3.50% | 6.50% | -4.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.87% | -0.84% | -6.88% | 0.21% | 2.10% | -3.75% |
FCF Yield | 13.08% | 12.89% | 8.49% | 0.07% | -0.60% | 10.21% |
Dividend Yield | - | - | - | - | 0.53% | 1.03% |
Payout Ratio | - | - | - | 137.36% | 12.50% | - |
Buyback Yield / Dilution | 28.05% | -0.73% | 28.57% | -39.99% | -0.01% | - |
Total Shareholder Return | 28.05% | -0.73% | 28.57% | -39.99% | 0.52% | 1.03% |